Home > Insider Trading > Filing (0001209191-21-038182)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1643921	N. Sangeeta Bhatia	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-06-02	285	$208.96	5,465	No	4	S	Direct
Common Stock	Disposition	2021-06-02	153	$210.01	5,312	No	4	S	Direct
Common Stock	Disposition	2021-06-02	121	$211.00	5,191	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $208.96 (range $208.64 to $209.48).
Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $210.01 (range $209.64 to $210.34).
Open market sales reported on this line occurred at a weighted average price of $211.00 (range $210.70 to $211.50).